Hal Turner Remarks

These 1170 dead after receiving the so-called “vaccine” are just the start, the tip of the iceberg. There will likely be many, many, more.

This “vaccine” is not a vaccine in any traditional sense. It does not contain any elements of the novel coronavirus which allegedly causes the disease COVID-19. Instead, this “vaccine” is actually experimental gene therapy which irreversibly alters a recipient’s DNA.

Scientists claim that their artificial “messenger RNA” which is what the “vaccine” actually contains, instructs the human body at the DNA level as to how to look for and respond to a specific protein on the surface of the novel coronavirus which causes COVID-19.

Once this “vaccine” is injected, it begins snipping parts of human DNA within cells, which alters the DNA of that person.

When tested on animals, 100 of the animals injected, died.

Rather than take this as a warning sign to stop what they were doing, scientists instead asked for — and got — a waiver from animal testing!

So this “vaccine” kills any animals injected with it. Is there any surprise thousands of people are dropping dead when it is injected into them?

Here’s the worst part:

When exposed to novel coronavirus in the wild, a person injected with this “vaccine” ends-up suffering a HYPER-IMMUNE RESPONSE which kills them.

Their immune systems go into a sort of hyper drive, a Cytokine storm – which then kills the person.

Within about 6 months, it is believed by many that so many humans will be dying from THE VACCINE, that government will try to cover it up by claiming a new mutation of COVID has come into being, and will blame this new (non-existent_ strain for the deaths.

Some Doctors are privately telling media outlets they expect fifty percent of the people receiving this new “vaccine” to be DEAD within 6 months. Click Here To Read More!!

As or Feb. 4, there had been 163 cases of Bell’s Palsy reported and 775 reports of anaphylaxis.

By Children’s Health Defense
Global Research, February 15, 2021
Children’s Health Defense 12 February 2021
Click Here To Read More!!

As The Defender reported today, the CDC is investigating the Feb. 8 death of a 36-year-old doctor in Tennessee who died about a month after receiving the second dose of a COVID vaccination. According to news reports, Dr. Barton Williams died from the adult form of multisystem inflammatory syndrome (MIS-A), a condition caused when the immune system attacks the body resulting in multi-system organ failure. New reports attributed the death to a reaction to an asymptomatic case of COVID, although Williams never tested positive for the virus.

Kylie Jenner’s friend Anastasia ‘Stassie Baby’ Karanikolaou poses in lingerie to grab the attention of millennials as she urges them to self-isolate

By HEIDI PARKER FOR DAILYMAIL.COM
PUBLISHED: 10:11 EST, 20 March 2020
UPDATED: 10:59 EST, 20 March 2020
Read More!!

Kylie Jenner urged her 166M followers to stay home – something she has already been doing all week – on Thursday after the Surgeon General of the US requested she do so.

And now her best friend Anastasia ‘Stassie Baby’ Karanikolaou is also taking to social media to let young people know they have to do their part to stop the spread of coronavirus and stay indoors.

The blonde model stripped down to her black undies to get her fans’ attention.

‘I’ve been social distancing and self quarantining for days now, not that i feel sick, just doing my part in taking the precautions to make sure everyone stays safe,’ began the star as she was seen cooking in her kitchen.

‘You may not be worried because you’re healthy and will be fine but you could still be a carrier and affect others with low immune systems.

‘It’s not just about you. we all need to do our part to keep everyone safe from this.

Environment

By Alliance for Natural Health International
Click Here To Read More!!

Most kids love a good muddy puddle to jump into or to dig in the dirt to find worms. So does their immune system. It’s what helps to prime it to protect them against infectious diseases. For kids with reduced access to outside space or those in city apartments less exposure to soil and other outdoor microbes may slow the development of the immune system.

Conversely, kids who live in urban areas may be exposed to fewer outdoor airborne pollutants due to there being fewer vehicles on the road and because they spend less time outside. However, exposure to more indoor pollutants such as second-hand tobacco smoke, household chemicals and fire retardant fabrics can be increased.

The lockdown legacy for children who’ve become used to spending less time outdoors is a likelihood of less connection to — or love for — nature. In turn, this is likely to manifest as having less interest in protecting the natural environment, which presents a critical challenge for the future of nature conservation and sustainability.

The increase in online learning and reliance on digital tech means children are being exposed to greater radio-frequency radiation sources, yet another factor in long-term health outcomes. Young kids are more sensitive to radiation sources so are particularly at heightened risk from the rise in use of electronic devices for learning.

Multiple studies have shown the low risk of the spread of COVID-19 in schools. The idea that kids might be driving the pandemic has also been proven unlikely. How much longer can we justify the damage pandemic restrictions are wreaking on our children and their futures?

Social interactions

By Alliance for Natural Health International
Click Here To Read More!!

Children and young people’s immune systems rely on their mixing and mingling to learn, mature and develop cross-reactivity to different bugs. The true health cost of enforced isolation and draconian lockdowns won’t be felt for some time yet, but unless specific action is taken to restore immune resilience, we could be facing a health crisis of unforeseen proportions in a few years time.

How will young people’s socialization skills and related neuronal development be affected? How will it affect their ability to find partners or jobs in the future? On the plus side, we’re likely to see a reduction in teenage pregnancies, but we don’t know how fertility in general might be impacted in the ‘pandemic generation’ as fertility is very closely associated with immune health.

“Be wary of hype and headlines”

By Nicoletta Lanese
Staff Writer
March 10, 2020
Read More!!

While vitamin C supplements pose little risk to consumers, other so-called “immune-boosting” products could be harmful.

Since the COVID-19 outbreak began in the United States, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have already issued warning letters to seven companies for selling fraudulent products that promise to cure, treat or prevent the viral infection. “These warning letters are just the first step,” FTC Chairman Joe Simons said in a news release. “We’re prepared to take enforcement actions against companies that continue to market this type of scam.”

Note that no evidence suggests that other so-called immune-boosting supplements — such as zinc, green tea or echinacea — help to prevent SARS-CoV-2 infections, Dr. Mark Mulligan, division director of the infectious diseases and vaccine center at NYU Langone Medical Center, told New York Times Parenting. “I do not recommend spending money on supplements for this purpose,” Mulligan said.

“The medical profession still doesn’t know exactly how to influence the immune system, despite what supplement products may claim,” Julie Stefanski, a registered dietitian nutritionist and spokeswoman for the Academy of Nutrition & Dietetics, told The Washington Post.

The FDA does not vet dietary supplements as it does pharmaceutical medications; that means that supplement manufacturers can place new products on the market without first proving that the substances are either safe or effective. The FDA and FTC step in after the fact to police a product that presents “a significant or unreasonable risk of illness or injury or that is otherwise adulterated or misbranded.”

These agencies rely heavily on reports from consumers, health care professionals and supplement manufacturers themselves to identify sketchy products and pull them off the market. That said, the FDA encourages consumers to stay informed and “be wary of hype and headlines,” saying that unsubstantiated claims crop up on supplement labels all the time and it’s often up to you to spot them.

When in doubt, the FDA recommends that you “let your health care professional advise you on sorting reliable information from questionable information.” Thankfully, in the case of vitamin C, supplements don’t typically cause harmful side effects, unless consumed in excess.

The vaccine Merck and IAVI have been developing uses a virus that infects livestock — vesicular stomatitis virus (VSV) — but is harmless to humans to present the SARS-2 spike protein to the immune system.

By MATTHEW HERPER @matthewherper
HELEN BRANSWELL @HelenBranswell
JANUARY 25, 2021
Click Here To Read More!!

Spike proteins project off the exterior of the virus. They attach to human cells, specifically cells with ACE-2 receptors, to trigger infection.

For the vaccine to work, Feinberg explained, it needs to be taken up by cells with ACE-2 receptors. But while the nasal passages have lots of cells with these receptors, muscle cells do not.

“So in a way, the vaccine’s ability to initiate the process of infecting target cells …. and eliciting an immune response, was limited potentially by the route of administration,” he said.

“Both individually as IAVI, and we hope through continued collaboration with Merck, we hope to continue to explore opportunities for either alternative routes of administration or additional modifications to the vector,” Feinberg said.

While Feinberg believes that the VSV-vectored Covid-19 vaccine is worth pursuing, the Phase 1 failure puts the Merck program — already at the back of the pack among major vaccine manufacturers — months or longer behind. That will complicate the path to approval for the vaccine if work on it continues because placebo-controlled clinical trials are becoming increasingly harder to conduct.

The alternative path, running clinical trials comparing the vaccine to another that has already been shown to be protective, requires more participants and runs a higher risk of failure given that some of the authorized vaccines are highly effective.

“It’s not going back to the drawing board, because we actually have a large amount of information to support what we think is worth doing next. But we want to be rigorous with ourselves and say, ‘Is what we’re doing adding value to the broader field?’” Feinberg said. “We think that we may have that possibility. But we need to generate the preclinical data that would merit going back into the clinic.”

In normal times, a vaccine manufacturer that had seen several competitors cross the finish line and get their vaccines into use would likely shelve a project — and this one may very well be headed in that direction. But enormous global demand for Covid-19 vaccines and the slower-than-hoped-for speed of vaccine production and rollout may create a different calculus in this situation.

The news is a reminder that developing new vaccines is difficult, and that the world is lucky that the first two — the Moderna and Pfizer/BioNTech shots — were so effective. In fact, long-term expertise in vaccine development has been less of an advantage than one would expect.

During Merck’s first quarter earnings call in April 2020, Roger Perlmutter, the company’s former head of research and development, said that in the past 25 years, there had been only seven new vaccines directed against previously unaddressed human pathogens. Four of those, he said, were developed by Merck.

Moderna had never developed a product of any kind. Nor had BioNTech, which was focusing mainly on experimental treatments for cancer. Pfizer sold the best-selling vaccine in the world, Prevnar 13, for the pneumococcus bacteria. Those companies developed vaccines with more than 90% efficacy against symptomatic Covid-19, something experts thought might not happen.

Meanwhile, the AstraZeneca/Oxford vaccine has been effective and is in use in the U.K. and India, though results haven’t been as impressive, reducing symptomatic infections by less than 70%. Sanofi, one of the world’s other vaccine makers, said in December that a setback in its early trials would push the delivery of its vaccine from the first half of this year to the second.

Experts have said that multiple vaccines will be needed to vaccinate everyone in the world. According to the World Health Organization, there are 64 potential vaccines in clinical development, including more than a dozen in the late stages of development.

Results from a U.S. trial testing a single dose of Johnson & Johnson’s vaccine are expected any day.

In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies

By MATTHEW HERPER @matthewherper
HELEN BRANSWELL @HelenBranswell
JANUARY 25, 2021
Click Here To Read More!!

Merck said Monday it will stop developing both of the current formulations of the Covid-19 vaccines the company was working on, citing inadequate immune responses to the shots.

Work will continue on at least one of the vaccines, which is being developed in partnership with the International AIDS Vaccine Initiative (IAVI), to see if using a different route of administration would improve how effective it is.

The announcement marks a shocking setback for one of the most storied vaccine makers, and will raise tensions around readouts expected soon from other companies, including Johnson & Johnson and the upstart NovaVax.

Merck said it remains committed to research on Covid-19 and will focus on two treatments it is developing. One is an antiviral medicine against SARS-CoV-2, the virus that causes the disease. The other is a medicine aimed at helping hospitalized patients by reducing the immune system’s over-response to the virus; it has already shown promise in clinical studies.

The myth, the legend

By Nicoletta Lanese
Staff Writer
March 10, 2020
Read More!!

Vitamin C, also known as ascorbic acid, became known as an immune-boosting supernutrient after two-time Nobel Prize winner Linus Pauling touted the substance’s supposed benefits in a series of books, Live Science previously reported. Pauling claimed that taking large doses of vitamin C could not only prevent the common cold, but also help thwart more severe illnesses like cancer and heart disease.

Since Pauling published his books, in the 1970s, his bolder claims have not stood up to scientific scrutiny. However, recent research does suggest that vitamin C supplements reduce the duration of colds in the general population, according to a 2013 review of several dozen studies.

The review found that vitamin C supplements taken during a cold can reduce the duration of the illness by 8% in adults and 14% in children. Practically, that means that supplementing vitamin C can shorten the duration of a cold by about one day. Participants in each study supplemented vitamin C for varying periods, but generally, the daily dose was at least 200 milligrams.

Several of the reviewed studies included people under intense physical stress, including marathon runners and soldiers training in the Arctic. Among these individuals, those who took vitamin C were about half as likely to catch a cold as those who did not take such supplements. But in the general population, the supplements did not prevent the common cold.

Likewise, no evidence suggests that vitamin C supplements can help prevent COVID-19, Dr. William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University Medical Center in Tennessee, told New York Times Parenting.

“If there’s going to be an advantage, it’s going to be very modest,” Schaffner said.

Some scientists are testing if vitamin C could alleviate symptoms and improve outcomes for patients with COVID-19 — if given in a high enough dose. Researchers at Zhongnan Hospital of Wuhan University launched a clinical trial with 140 patients in February to test whether ultrahigh doses of vitamin C, delivered intravenously, could treat the viral infection more effectively than a placebo. The test group will receive infusions twice a day for seven days, with each infusion containing 12g of vitamin C. (The daily recommendation for an adult man is only 90mg.)

The trial will be completed in September, and no results are yet available, according to ClinicalTrials.gov. In the meantime, Chinese scientists have launched dozens of other clinical trials as well, testing everything from antivirals to antibody therapies to traditional Chinese medicines.

Why vitamin C won’t ‘boost’ your immune system against the coronavirus

By Nicoletta Lanese
Staff Writer
March 10, 2020
Read More!!

Vitamin C is extremely unlikely to help people fight off the new coronavirus.

When afflicted with the common cold, many people chug orange juice and swallow vitamin C supplements in an attempt to “boost” their immune systems. But vitamin C supplements don’t ward off the common cold in most people, and there’s even less evidence that they grant immunity against SARS-CoV-2, the virus that causes COVID-19.